Cargando…

Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013

PURPOSE: Our study aimed to report the annual changes in lung cancer statistics and analyze trends in sociodemographic, medical, and financial factors from 2003 to 2013 in the national database from the Korean National Health Insurance (KNHI). MATERIALS AND METHODS: Among 7,489 patients with code C3...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dohun, Kim, So Young, Suh, Beomseok, Park, Jong Hyock
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056952/
https://www.ncbi.nlm.nih.gov/pubmed/28882022
http://dx.doi.org/10.4143/crt.2017.050
_version_ 1783341424437100544
author Kim, Dohun
Kim, So Young
Suh, Beomseok
Park, Jong Hyock
author_facet Kim, Dohun
Kim, So Young
Suh, Beomseok
Park, Jong Hyock
author_sort Kim, Dohun
collection PubMed
description PURPOSE: Our study aimed to report the annual changes in lung cancer statistics and analyze trends in sociodemographic, medical, and financial factors from 2003 to 2013 in the national database from the Korean National Health Insurance (KNHI). MATERIALS AND METHODS: Among 7,489 patients with code C34 in KNHI database, only lung cancer patients newly diagnosed after 2003 were included in the study population, for a total of 4,582 patients. Descriptive statistics were used to characterize treatment patterns and medical costs according to sociodemographic factors. RESULTS: Approximately 70% of subjects were male, and the mean age was 67 years. Around 46% of patients were over 70 years old, and 12% were over 80 years old. The medical costs were highest for patients younger than 60 and lowest for those over 80 years old. Surgery was more common in younger patients, while “no treatment” increased greatly with age. In trend analysis, the proportions of aging (p for trend < 0.001), female (p for trend=0.003), metropolitan/urban (p for trend=0.041), and lowest or highest-income patients (p for trend=0.004) increased over time, along with the prevalence of surgery as the primary treatment (p for trend < 0.001). There was also a trend with regard to change in medical costs (p for trend < 0.001), in that those of surgery and radiotherapy increased. CONCLUSION: Surgery as a curative treatment has increased over the past decade. However, the elderly, suburban/rural residents, and low-income patients were more likely to be untreated. Therefore, active measures are required for these increasingly vulnerable groups.
format Online
Article
Text
id pubmed-6056952
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-60569522018-07-27 Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013 Kim, Dohun Kim, So Young Suh, Beomseok Park, Jong Hyock Cancer Res Treat Original Article PURPOSE: Our study aimed to report the annual changes in lung cancer statistics and analyze trends in sociodemographic, medical, and financial factors from 2003 to 2013 in the national database from the Korean National Health Insurance (KNHI). MATERIALS AND METHODS: Among 7,489 patients with code C34 in KNHI database, only lung cancer patients newly diagnosed after 2003 were included in the study population, for a total of 4,582 patients. Descriptive statistics were used to characterize treatment patterns and medical costs according to sociodemographic factors. RESULTS: Approximately 70% of subjects were male, and the mean age was 67 years. Around 46% of patients were over 70 years old, and 12% were over 80 years old. The medical costs were highest for patients younger than 60 and lowest for those over 80 years old. Surgery was more common in younger patients, while “no treatment” increased greatly with age. In trend analysis, the proportions of aging (p for trend < 0.001), female (p for trend=0.003), metropolitan/urban (p for trend=0.041), and lowest or highest-income patients (p for trend=0.004) increased over time, along with the prevalence of surgery as the primary treatment (p for trend < 0.001). There was also a trend with regard to change in medical costs (p for trend < 0.001), in that those of surgery and radiotherapy increased. CONCLUSION: Surgery as a curative treatment has increased over the past decade. However, the elderly, suburban/rural residents, and low-income patients were more likely to be untreated. Therefore, active measures are required for these increasingly vulnerable groups. Korean Cancer Association 2018-07 2017-09-04 /pmc/articles/PMC6056952/ /pubmed/28882022 http://dx.doi.org/10.4143/crt.2017.050 Text en Copyright © 2018 by the Korean Cancer Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Dohun
Kim, So Young
Suh, Beomseok
Park, Jong Hyock
Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013
title Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013
title_full Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013
title_fullStr Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013
title_full_unstemmed Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013
title_short Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003-2013
title_sort trend analysis for the choice and cost of lung cancer treatment in south korea, 2003-2013
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056952/
https://www.ncbi.nlm.nih.gov/pubmed/28882022
http://dx.doi.org/10.4143/crt.2017.050
work_keys_str_mv AT kimdohun trendanalysisforthechoiceandcostoflungcancertreatmentinsouthkorea20032013
AT kimsoyoung trendanalysisforthechoiceandcostoflungcancertreatmentinsouthkorea20032013
AT suhbeomseok trendanalysisforthechoiceandcostoflungcancertreatmentinsouthkorea20032013
AT parkjonghyock trendanalysisforthechoiceandcostoflungcancertreatmentinsouthkorea20032013